First U.S. Biosimilar Drug Given the Green Light

Novartis given green light by U.S. Court of Appeals for the Federal Circuit to launch the first biosimilar drug in the United States. Biosimilar medications aim to copy the biologic products that are made inside living cells. Biosimilar medications have been available in Europe for nearly a decade. [9/8/15]